Member Info for _Mr_Big

Can sp be negative ?

Dave's a man of his word.

Met Dave for lunch.
He's saying that the Nova team is working hard on getting rid of this blue share price anomaly today, but so far, they've been unable to bring it into the usual red range.
He's hoping that the issue will be resolved by close of business and Novacyt will be back on its track of shareholder value destruction.

He'd like to apologise for any inconvenience caused to the shareholders by this blue glimmer of hope.

Just called Mandy and asked her about the blue.
She doesn't know either. Says nobody in the nova office knows what this means.

"Allmond looked and sounded Ill in his interview yesterday"

Katie looked great, as always though!

Don't know.
Been in nova for almost a year, and it's the first time I see it.

Should we be worried?

Well done for selling the dip.
Don't forget to buy on the spike.

#getrichquick

"If cash is just there to pay directors salaries it won't be valued in the share price"
SP won't go below asset value if that's what you're suggesting.
Sitting on cash is better than drowning in debt, so, again, you're wrong to claim it ain't "valued in share price", whatever the f.ck this phrase means.

An asset is an asset.
Don't be a dumb squid.

Almost trading at cash position, yes.
Drop way overdone, but overall, 2021 performance is truly shocking.

Good points:
- Very strong cash position.
- Semi Decent 2022 outlook with hopes of sales boosts from next covid variant.
- Shift away from covid revenues.
- Rapid development of private testing sales and international sales.

Bad points:
- Failed on their revenue guidance (Was at £104m at some point in summer (£100m private + £4m DHSC), then quietly downgraded to £100m, then to £97m to come in at £95m at year end ffs).
- Failed to boost sales this winter when competitors were reporting huge upside. How and Why?
- Technically, earnings for the year of £7m. (£36m ebitda before exceptional £29m DHSC stock write-down).
- DHSC owing us £70m (sales + stock write-down) or at least £41m sales. Why not pursuing the claim?

Basically, almost wort case scenario for 2021. **** poor performance with no explanations about why it had to be so bad.
£2 per share is a joke, but £5 ain't looking probable any more, and £4 would be very optimistic. Mid £3s is a more realistic estimate now, which is an exceptional management f.ck up.

Anyone else calling a blue finish?
If not for today, then for the week at least.

HKK - not quite true.
Guidance mentioned down £3m, but we also had extra £4m DHSC contract in summer, outside of private sales.

£95m revenue puts us as £6m (6%) lower than guidance.
Disappointing, but market's full of ****e at the moment, so an extra £1m in profits wouldn't have improved the SP.

Is that the WHO who let the dogs out?

I'll dump mine at £4.99 then.

this probably is your last chance at these prices

Too late now. Gravy train has left the station.
Choo Choo!

Next stop - £5 on Monday RNS!

Covid? What covid?

Putin's about to invade an area of Ukraine that doesn't even want to be part of Ukraine, and you're still talking about 300 people in UK dying of covid per day.

You really need to focus on more relevant issues!

wee wee mon amy!

out of this one over the weekend!

Here, I said it. Bet you haven't read this phrase on this board for months.

I wouldn't be surprised to see blue t 4.30.

Especially considering the shake, rattle & roll in the morning.